Why Are We Failing to Implement Imaging Studies with Radiolabelled New Molecular Entities in Early Oncology Drug Development?

In early drug development advanced imaging techniques can help with progressing new molecular entities (NME) to subsequent phases of drug development and thus reduce attrition. However, several organizational, operational, and regulatory hurdles pose a significant barrier, potentially limiting the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleem, Azeem, Murphy, Philip, Plisson, Christophe, Lahn, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151371/
https://www.ncbi.nlm.nih.gov/pubmed/25202719
http://dx.doi.org/10.1155/2014/269605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151371/
https://www.ncbi.nlm.nih.gov/pubmed/25202719
http://dx.doi.org/10.1155/2014/269605

Ejemplares similares